In recent years, with the approval of many PD-1 checkpoint inhibitors and the success of lots of clinical trials on cancer immunotherapy, people become more confident with overwhelming the incurable disease. However, there still remain unsolved problems. Inviting top specialists domestic and abroad, Bioon is leading the way to new directions of diagnosis and treatment!

This symposium is one of the top-ranked meetings in the field of tumor microenvironment and cancer immunotherapy in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of tumor microenvironment & tumor immunity in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!